When disaster strikes, the expertise and medical support delivered by federal Disaster Medical Assistance Teams, which include RTs, are often the difference between life and death for victims.
This month’s technology insider explores video laryngoscopy, a device that, due to its durability and portability, has proven to be a favored option for airway management during disaster situations.
Commercially available since 1997, adaptive aerosol delivery (AAD) has undergone improvements as it attempts to edge out conventional nebulizing methods.
Research conducted at Boston Children’s Hospital indicates that obesity might cause asthma via factors in the immune system, and suggests a new way of treating the condition in obese people —who often respond poorly to standard asthma medications.
Denmark has approved both mid- and high-strength dosage forms of AirFluSal Forspiro for the continuous treatment of persistent asthma and/or symptomatic treatment of COPD.
A new study demonstrates the five-year durability of the treatment for asthma patients. The therapy, which calls for heat to be applied to a patient’s airway during a bronchoscopy procedure, was approved by the FDA in April 2010.
A UK-based effort encourages providers to help patients use their inhalers properly. This supports recent findings that many asthma patients do not know how to correctly self-administer their medication.
The findings have significant potential for modeling lung disease, screening drugs, studying human lung development, and generating lung tissue for transplantation, according to the authors.
Tetraplegia, the loss of function in all limbs, was associated with a greater risk of central sleep disordered breathing, than injuries occurring lower in the spinal cord.
British researchers find that asthma patients overestimate the control they have over their disease, even when they’re experiencing frequent exacerbations.